Mickey (MCK) news

MCKESSON CORP <MCK.N>: LEERINK PARTNERS RAISES TARGET PRICE TO $1,070 FROM $1,030

MCKESSON CORP : LEERINK PARTNERS RAISES TARGET PRICE TO $1,070 FROM $1,030

Truist Downgrades Option Care Health to Buy From Hold on Heels of Announced Sale to McKesson, CD&R; Adjusts PT to $32.05 From $30

05:08 AM EDT, 10/07/2026 (MT Newswires) -- Option Care Health (OPCH) has an average rating of overweight and mean price target of $30.46, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Dow Jones Top Company Headlines at 3 AM ET: Shell's Refining Margin Surges to Record | A ...

Shell's Refining Margin Surges to Record Refining margins came in at $42 a barrel in the third quarter compared with $24 a barrel in the second, driven by volatility stemming from the conflict in the Middle East. ---- A High-Stakes Gambit Clinched Paramount's Warner Deal David Ellison's megadeal combining Paramount and Warner Bros. closed Tuesday, ushering in a new era for Hollywood. ---- LG Electronics' Preliminary Earnings Disappoint The South Korean consumer-electronics company has continued to expand aggressively into fast-growing businesses in the AI era, such as data-center cooling systems. ---- Jaguar Ditches the Pink Branding in Unveil of Its Big, Sleek Type 01 EV Long-promised vehicle will start around $130,000 in the U.S. as Jaguar aims to sell fewer cars at higher prices. ---- Constellation Brands Profit Rises on Higher Beer, Spirits Sales Sales in Constellation's beer business, which includes Corona and Modelo, rose 5%, while its wine and spirits business saw a 17% increase in sales. ---- Fair Isaac to Cut About 15% of Workforce as Competition Intensifies The job cuts come as the company behind the FICO credit score faces new competitive pressure. ---- FlyDubai Attacker Was Part of Pilot Hiring Spree at Fast-Growing Airline Authorities and industry insiders are now questioning whether the airline's fast growth contributed to last week's near catastrophe. ---- Penguin Solutions' Memory Business Soars on AI Demand. Can Its Stock Rally Again? Penguin Solutions posted fiscal fourth-quarter earnings of $1 a share, a 133% year-over-year rise, and net sales of $567 million, up 68%. ---- Google and Constellation Energy Strike a Sweeping Nuclear-Power Deal The deal is the largest-ever "uprate" project, one that squeezes more power out of existing reactors, between a nuclear-power provider and a tech company. ---- AI-Computing Startup Lambda Is Raising $4 Billion in Final Round Before Planned IPO The Nvidia-backed company is targeting an IPO in 2027. ---- Skydance's Ambitious Goals Face a Steep Road Skydance fa

Dow Jones Top Company Headlines at 9 PM ET: Constellation Brands Profit Rises on Higher Beer, Spirits Sales | Fair ...

Constellation Brands Profit Rises on Higher Beer, Spirits Sales Sales in Constellation's beer business, which includes Corona and Modelo, rose 5%, while its wine and spirits business saw a 17% increase in sales. ---- Fair Isaac to Cut About 15% of Workforce as Competition Intensifies The job cuts come as the company behind the FICO credit score faces new competitive pressure. ---- Penguin Solutions' Memory Business Soars on AI Demand. Can Its Stock Rally Again? Penguin Solutions posted fiscal fourth-quarter earnings of $1 a share, a 133% year-over-year rise, and net sales of $567 million, up 68%. ---- Google and Constellation Energy Strike a Sweeping Nuclear-Power Deal The deal is the largest-ever "uprate" project, one that squeezes more power out of existing reactors, between a nuclear-power provider and a tech company. ---- AI-Computing Startup Lambda Is Raising $4 Billion in Final Round Before Planned IPO The Nvidia-backed company is targeting an IPO in 2027. ---- Skydance's Ambitious Goals Face a Steep Road Skydance faces a tough task achieving its goals against a tough media and entertainment industry backdrop. Wall Street is taking a wait-and-see approach. ---- CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%. ---- Mistral to Release New AI Model to Better Compete With U.S. Rivals Mistral launched a public preview of the model on Tuesday and plans to release its trained parameters on Oct. 27. ---- Uber to Expand Uber Eats Service with $2.3 Billion Acquisition of Catering Platform The deal gives Uber Eats access to ezCater's network of more than 140,000 restaurants in the U.S., which generate over $2.5 billion in annual gross bookings. ---- Lamb Weston Says Cost-Saving Efforts Are Paying Off The french fry maker said profit and sales exceeded expectations in the latest quarter, citing strong demand and steps the company has taken to counter rising costs. -

Dow Jones Top Company Headlines at 7 PM ET: Constellation Brands Profit Rises on Higher Beer, Spirits Sales | Google ...

Constellation Brands Profit Rises on Higher Beer, Spirits Sales Sales in Constellation's beer business, which includes Corona and Modelo, rose 5%, while its wine and spirits business saw a 17% increase in sales. ---- Google and Constellation Energy Strike a Sweeping Nuclear-Power Deal The deal is the largest-ever "uprate" project, one that squeezes more power out of existing reactors, between a nuclear-power provider and a tech company. ---- Fair Isaac to Cut About 15% of Workforce as Competition Intensifies The job cuts come as the company behind the FICO credit score faces new competitive pressure. ---- AI-Computing Startup Lambda Is Raising $4 Billion in Final Round Before Planned IPO The Nvidia-backed company is targeting an IPO in 2027. ---- Uber to Expand Uber Eats Service with $2.3 Billion Acquisition of Catering Platform The deal gives Uber Eats access to ezCater's network of more than 140,000 restaurants in the U.S., which generate over $2.5 billion in annual gross bookings. ---- Skydance's Ambitious Goals Face a Steep Road Skydance faces a tough task achieving its goals against a tough media and entertainment industry backdrop. Wall Street is taking a wait-and-see approach. ---- Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief The move makes the needle- and medical-device maker the latest company to pledge to expand domestic manufacturing to secure an exemption from the Trump administration's tariffs. ---- Penguin Solutions' Memory Business Soars on AI Demand. Can Its Stock Rally Again? Penguin Solutions posted fiscal fourth-quarter earnings of $1 a share, a 133% year-over-year rise, and net sales of $567 million, up 68%. ---- Lamb Weston Says Cost-Saving Efforts Are Paying Off The french fry maker said profit and sales exceeded expectations in the latest quarter, citing strong demand and steps the company has taken to counter rising costs. ---- Energy Transfer to Acquire Vaquero Midstream for $2.63 Billion The deal consists of $1.95 billion in cash and about 33.3 million new

Dow Jones Top Company Headlines at 5 PM ET: Constellation Brands Profit Rises on Higher Beer, Spirits Sales | Google ...

Constellation Brands Profit Rises on Higher Beer, Spirits Sales Sales in Constellation's beer business, which includes Corona and Modelo, rose 5%, while its wine and spirits business saw sales increase 17%. ---- Google and Constellation Energy Strike a Sweeping Nuclear-Power Deal The deal is the largest-ever "uprate" project, one that squeezes more power out of existing reactors, between a nuclear-power provider and a tech company. ---- AI-Computing Startup Lambda Is Raising $4 Billion in Final Round Before Planned IPO The Nvidia-backed company is targeting an IPO in 2027. ---- Uber to Expand Uber Eats Service with $2.3 Billion Acquisition of Catering Platform The deal gives Uber Eats access to ezCater's network of more than 140,000 restaurants in the U.S., which generate over $2.5 billion in annual gross bookings. ---- Skydance Sets Ambitious Financial Targets. What It Must Overcome. Skydance faces a tough task achieving its goals against a tough media and entertainment industry backdrop. Wall Street is taking a wait-and-see approach. ---- Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief The move makes the needle- and medical-device maker the latest company to pledge to expand domestic manufacturing to secure an exemption from the Trump administration's tariffs. ---- Lamb Weston Says Cost-Saving Efforts Are Paying Off The french fry maker said profit and sales exceeded expectations in the latest quarter, citing strong demand and steps the company has taken to counter rising costs. ---- Energy Transfer to Acquire Vaquero Midstream for $2.63 Billion The deal consists of $1.95 billion in cash and about 33.3 million newly issued Energy Transfer common units. ---- Fintech Plaid Bets on Credit Scores to Fuel Next Phase of Growth EXCLUSIVE: Plaid is doubling down on its credit-scoring business with new AI models as the company aims to chart its next era of growth with a suite of products beyond its core business. ---- CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billi

Update: S&P 500, Nasdaq Hit Record Highs as Focus Shifts to Fed Minutes

04:48 PM EDT, 10/06/2026 (MT Newswires) -- (Updates with market moves at the end of the day, and other changes, if any.) The S&P 500 and the Nasdaq Composite hit record highs on Tuesday as Treasury yields declined ahead of the Federal Reserve's meeting minutes due Wednesday. The S&P 500 added 0.6% to settle at 7,818.93, while the Nasdaq gained 0.5% to 27,599.79 to notch a back-to-back new peak. Both are up for the fourth and fifth day in a row, respectively. The Dow Jones Industrial Average rose 0.5% to 51,521.28, extending its rally into the fourth session. Barring healthcare, all sectors ended in the green, led by utilities. The 10-year Treasury yield was last down 3.2 basis points at 5.28%, while the two-year rate fell 3.8 basis points to 4.80%. The Fed will publish the minutes from its September meeting on Wednesday, offering insights into the monetary policy trajectory. Policymakers announced a 25-basis-point rate increase at the meeting, marking the first rate hike in just over three years aimed at bringing elevated inflation back to the 2% target. Markets are currently pricing in an 81% probability that the Fed will keep its benchmark rate steady later this month, according to the CME FedWatch tool. In economic news, the US trade deficit increased in August to its highest level since March 2025 as imports hit a record high, official data showed Tuesday. The trade deficit widened in part due to an artificial intelligence-induced surge in capital goods imports, Grace Zwemmer, US economist at Oxford Economics, said in a note. "Although net trade is on track to pose a sizeable drag on (third-quarter gross domestic product), roughly half of the drag will be offset by a 1.4 (percentage point) contribution to GDP growth from booming equipment spending," Zwemmer said. Brent crude oil was up 0.7% at $100.99 a barrel in Tuesday late-afternoon trade, while West Texas Intermediate rose 0.4% to $89.81. Attacks on tankers in the Strait of Hormuz have intensified this month even as oil shipments through the critical ener

Sector Update: Healthcare Stocks Mixed Late Afternoon

03:51 PM EDT, 10/06/2026 (MT Newswires) -- Healthcare stocks were mixed late Tuesday afternoon, with the NYSE Healthcare Index up 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.3%. The iShares Biotechnology ETF (IBB) fell 2.5%. In corporate news, McKesson (MCK) and CD&R have entered into a definitive agreement to buy Option Care Health (OPCH) for $32.05 per share, reflecting a total enterprise value of about $5.8 billion. McKesson shares were up 0.7%, and Option Care surged 32%. Jupiter Neurosciences (JUNS) said Tuesday it has started a process to evaluate strategic options, including sale or licensing, strategic partnerships, and business combinations. Its shares jumped 15%. Stryker (SYK) Chief Executive Kevin Lobo is stepping down after 14 years and transitioning to the role of executive chair of the board, effective Jan. 1, as part of a planned leadership transition, the company said Tuesday. He will be succeeded by President and Chief Operating Officer Spencer Stiles, who will also be appointed to the board, the company said. The company's shares were down 2.6%. Becton Dickinson (BDX) plans to invest $19 billion in the US over several years as part of a government partnership to expand domestic manufacturing and strengthen medical supply chains, the company said Tuesday. Its shares were down marginally.

Dow Jones Top Company Headlines at 3 PM ET: Google and Constellation Energy Strike a Sweeping Nuclear-Power Deal | AI-Computing ...

Google and Constellation Energy Strike a Sweeping Nuclear-Power Deal The deal is the largest-ever "uprate" project, one that squeezes more power out of existing reactors, between a nuclear power provider and a tech company. ---- AI-Computing Startup Lambda Is Raising $4 Billion in Final Round Before Planned IPO The Nvidia-backed company is targeting an IPO in 2027. ---- Uber to Expand Uber Eats Service with $2.3 Billion Acquisition of Catering Platform The deal gives Uber Eats access to ezCater's network of more than 140,000 restaurants in the U.S., which generate over $2.5 billion in annual gross bookings. ---- Skydance Sets Ambitious Financial Targets. What It Must Overcome. Skydance faces a tough task achieving its goals against a tough media and entertainment industry backdrop. Wall Street is taking a wait-and-see approach. ---- Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief The move makes the needle- and medical-device maker the latest company to pledge to expand domestic manufacturing to secure an exemption from the Trump administration's tariffs. ---- Lamb Weston Says Cost-Saving Efforts Are Paying Off The french fry maker said profit and sales exceeded expectations in the latest quarter, citing strong demand and steps the company has taken to counter rising costs. ---- Energy Transfer to Acquire Vaquero Midstream for $2.63 Billion The deal consists of $1.95 billion in cash and about 33.3 million newly issued Energy Transfer common units. ---- Fintech Plaid Bets on Credit Scores to Fuel Next Phase of Growth EXCLUSIVE: Plaid is doubling down on its credit-scoring business with new AI models as the company aims to chart its next era of growth with a suite of products beyond its core business. ---- CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%. ---- Mistral to Release New AI Model to Better Compete With U.S. Rivals Mistral l

Sector Update: Healthcare Stocks Mixed Tuesday Afternoon

01:46 PM EDT, 10/06/2026 (MT Newswires) -- Healthcare stocks were mixed Tuesday afternoon, with the NYSE Healthcare Index up 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.3%. The iShares Biotechnology ETF (IBB) fell 2.5%. In corporate news, McKesson (MCK) and CD&R have entered into a definitive agreement to buy Option Care Health (OPCH) for $32.05 per share, reflecting a total enterprise value of about $5.8 billion. McKesson shares were up 0.3%, and Option Care surged 33%. Jupiter Neurosciences (JUNS) said Tuesday it has started a process to evaluate strategic options, including sale or licensing, strategic partnerships, and business combinations. Its shares jumped 13%. Stryker (SYK) Chief Executive Kevin Lobo is stepping down after 14 years and transitioning to the role of executive chair of the board, effective Jan. 1, as part of a planned leadership transition, the company said Tuesday. He will be succeeded by President and Chief Operating Officer Spencer Stiles, who will also be appointed to the board, the company said. The company's shares were down 2%. ArriVent BioPharma (AVBP) shares fell 48% after it said Tuesday its phase 3 Furvent trial of firmonertinib did not achieve its primary progression-free survival goal in people with non-small cell lung cancer.

McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal

01:30 PM EDT, 10/06/2026 (MT Newswires) -- Drug distributor McKesson (MCK) and private investment firm Clayton Dubilier & Rice agreed to acquire Option Care Health (OPCH) in a roughly $5.8 billion deal, sending the home infusion services provider's shares soaring Tuesday. Option Care shareholders will receive $32.05 per share, a premium of about 37% to the stock's Monday closing price, the companies said Tuesday. Clayton Dubilier & Rice, or CD&R, will own a roughly 51% majority stake in Option Care, while McKesson will invest about $1.4 billion for the remaining 49%. The agreement also establishes a framework for McKesson to acquire CD&R's interest in Option Care in the future, they said in a statement. Option Care shares were up 33% in afternoon trade, paring this year's loss to 2.4%. McKesson shares were up 0.3%, bringing its year-to-date gains to roughly 12%. Option Care describes itself as the nation's largest independent provider of home and alternate-site infusion services, serving patients across all 50 states. McKesson Chief Executive Brian Tyler said the investment fits its strategy of expanding access to therapies in lower-cost community settings. The deal is expected to close in the first half of 2027, subject to Option Care stockholder approval and other conditions. Option Care will remain a separate company led by its own management team, while its shares will be delisted from the Nasdaq Stock Exchange. The company withdrew its financial guidance and will not host a call with its third-quarter results scheduled for Nov. 4. Separately, Deutsche Bank said the deal would mark "another meaningful step" in McKesson's strategy to expand further downstream in specialty care. "We suspect (McKesson) likely involved CD&R to limit its upfront capital commitment while still gaining strategic exposure to the asset, with a potential path to full ownership over time," the brokerage said in a Tuesday note to clients prior to the deal's announcement. In August, McKesson agreed to acquire Precision Medicine in a trans

Sector Update: Healthcare

01:15 PM EDT, 10/06/2026 (MT Newswires) -- Healthcare stocks were mixed Tuesday afternoon, with the NYSE Healthcare Index up 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.2%. The iShares Biotechnology ETF (IBB) shed 2.2%. In corporate news, McKesson (MCK) and CD&R have entered into a definitive agreement to buy Option Care Health (OPCH) for $32.05 per share, reflecting a total enterprise value of about $5.8 billion. McKesson shares were up 0.2%, and Option Care surged 33%.

Dow Jones Top Company Headlines at 1 PM ET: AI Neocloud Lambda Is Raising $4 Billion in Final Round Before Planned IPO | Uber ...

AI Neocloud Lambda Is Raising $4 Billion in Final Round Before Planned IPO The Nvidia-backed company is targeting an IPO in 2027. ---- Uber to Expand Uber Eats Service with $2.3 Billion Acquisition of Catering Platform The deal gives Uber Eats access to ezCater's network of more than 140,000 restaurants in the U.S., which generate over $2.5 billion in annual gross bookings. ---- Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief The move makes the needle- and medical-device maker the latest company to pledge to expand domestic manufacturing to secure an exemption from the Trump administration's tariffs. ---- Lamb Weston Says Cost-Saving Efforts Are Paying Off The french fry maker said profit and sales exceeded expectations in the latest quarter, citing strong demand and steps the company has taken to counter rising costs. ---- Energy Transfer to Acquire Vaquero Midstream for $2.63 Billion The deal consists of $1.95 billion in cash and about 33.3 million newly issued Energy Transfer common units. ---- Fintech Plaid Bets on Credit Scores to Fuel Next Phase of Growth EXCLUSIVE: Plaid is doubling down on its credit-scoring business with new AI models as the company aims to chart its next era of growth with a suite of products beyond its core business. ---- CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%. ---- Mistral to Release New AI Model to Better Compete With U.S. Rivals Mistral launched a public preview of the model on Tuesday and plans to release its trained parameters on Oct. 27. ---- SoftBank-Backed DayOne Plans to Raise Up to $5 Billion in U.S. IPO Singapore-based DayOne Data Centers plans to list its American depositary shares on the Nasdaq by the end of the year. ---- Emmy Awards Will Leave Broadcast TV for Amazon's Prime Video The six-year deal ends the awards show's decadeslong rotation among ABC, CBS, Fox and NBC. ---- What

Top Midday Stories: Google Strikes 20-Year Nuclear Power Deal With Constellation; Marvell Raises Revenue Guidance for 2026-27

11:45 AM EDT, 10/06/2026 (MT Newswires) -- All three major US stock indexes were up in late-morning trading Tuesday, as oil prices and Treasury yields were down. In company news, Alphabet's (GOOG, GOOGL) Google has entered into a 20-year deal with Constellation Energy (CEG) to add 890 megawatts of nuclear power to the PJM interconnection grid, the companies said Tuesday. The agreement will enable over $4.3 billion in investments in new equipment and technology at 11 Constellation nuclear facilities in Illinois, Pennsylvania and New Jersey, the companies said. Alphabet's Class C and Class A shares were up 0.3% and 0.6%, respectively, around midday. Constellation shares were up 13.7%. Marvell Technology (MRVL) now expects to generate revenue of $12 billion in 2026 and $18 billion in 2027, up from its previous guidance of a combined $20 billion over that period, Chairman and Chief Executive Matthew Murphy said Tuesday at a conference, according to a transcript. Marvell shares were up 7.0%. McKesson (MCK) and CD&R have entered into a definitive agreement to acquire Option Care Health (OPCH) for $32.05 per share, reflecting a total enterprise value of about $5.8 billion, the companies said Tuesday. After the deal closes, which is expected to occur in H1 2027, CD&R will hold a majority interest of 51% in Option Care Health, while McKesson will invest $1.4 billion to hold the remaining 49%, the companies said. McKesson shares were up 0.1%, while Option Care shares were up 32.7%. Uber Technologies (UBER) has agreed to acquire ezCater for $2.3 billion in cash, the ride-hailing company said Tuesday. The deal, expected to close in the coming months, will expand Uber's catering orders and give restaurants access to larger orders and more customers, the company said. Uber shares were down 0.4%. Energy Transfer (ET) said Tuesday it has entered into a definitive agreement to acquire Vaquero Midstream in a bolt-on deal valued at about $2.63 billion. The deal consideration will consist of $1.95 billion in cash and about 33.3 mill

Updated Version 4 - McKesson and CD&R to privatize infusion therapy provider Option Care in a $5.8 billion deal

McKesson will spend approximately $1.4 billions to acquire a 49% stake in Option Care. The transaction is expected to be completed in the first half of 2027. Option Care is the largest independent infusion therapy service provider in the United States. McKesson (MCK.N), a pharmaceutical distributor, and private equity firm Clayton Dubilier & Rice have reached an agreement on Tuesday to take Option Care Health (OPCH.O), an infusion therapy provider, private in a transaction valued at about $5.8 billions including debt. The offer price of $32.05 per share represents a 37.1% premium over the latest closing price of Option Care. The company’s shares rose 32.8%, closing at $31.03. For McKesson, this deal represents the latest move in its effort to broaden its healthcare services portfolio and follows another private equity acquisition of a home healthcare provider, Enhabit. Option Care Health, as the largest independent infusion provider in the US, operates through over 197 locations, serving more than 308,000 patients annually with home and outpatient infusion, specialty pharmacy, and complex condition care. JPMorgan analyst Lisa Gill commented that McKesson’s focus on specialty and community healthcare makes this acquisition very attractive, allowing the company to capitalize on supply chain efficiencies and collaborate with Option Care Health in complex chronic medication management. As the population ages and more patients choose treatment outside of high-cost hospital settings, demand for home healthcare in the US is growing. Under the deal, McKesson will invest about $1.4 billions to acquire a 49% minority stake and will retain an option to acquire the remaining 51% from CD&R at a future date. Option Care Health will continue to operate as an independent company led by its own management. According to Leerink Partners analyst Michael Cherny, in a Monday evening report, this transaction aligns McKesson with the trend of shifting healthcare delivery from hospitals and medical institutions to alternate sites. Given that McKesson currently operates Canada’s leading infusion network, Inviva, this deal will further expand its footprint in the US home infusion services sector. Revenues from McKesson’s oncology and multi-specialty businesses (including infusion services) hit $14.2 billions in the latest quarter, up 33% from the prior year. The transaction is expected to close in the first half of 2027, at which point Option Care Health will become a private company.

Dow Jones Top Company Headlines at 11 AM ET: Uber to Expand Uber Eats Service with $2.3 Billion Acquisition of Catering Platform | Becton ...

Uber to Expand Uber Eats Service with $2.3 Billion Acquisition of Catering Platform The deal gives Uber Eats access to ezCater's network of more than 140,000 restaurants in the U.S., which generate over $2.5 billion in annual gross bookings. ---- Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief The move makes the needle- and medical-device maker the latest company to pledge to expand domestic manufacturing to secure an exemption from the Trump administration's tariffs. ---- Lamb Weston Lifts Fiscal 2027 Outlook Lamb Weston raised its outlook for the year after reporting higher-than-expected adjusted earnings and sales in its fiscal first quarter, driven by continued momentum in North America. ---- Energy Transfer to Acquire Vaquero Midstream for $2.63 Billion The deal consists of $1.95 billion in cash and about 33.3 million newly issued Energy Transfer common units. ---- Fintech Plaid Bets on Credit Scores to Fuel Next Phase of Growth EXCLUSIVE: Plaid is doubling down on its credit-scoring business with new AI models as the company aims to chart its next era of growth with a suite of products beyond its core business. ---- CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%. ---- Mistral to Release New AI Model to Better Compete With U.S. Rivals Mistral launched a public preview of the model on Tuesday and plans to release its trained parameters on Oct. 27. ---- SoftBank-Backed DayOne Plans to Raise Up to $5 Billion in U.S. IPO Singapore-based DayOne Data Centers plans to list its American depositary shares on the Nasdaq by the end of the year. ---- Emmy Awards Will Leave Broadcast TV for Amazon's Prime Video The six-year deal ends the awards show's decadeslong rotation among ABC, CBS, Fox and NBC. ---- What Oura's Stalled IPO Tells Us About One-Hit Wonders Oura pitched itself as a tech platform, but investors saw through that. ---- KKR

BUZZ-Option Care Health surges after $5.8 billions privatization deal

Latest developments on October 6 - ** Option Care Health (OPCH.O) shares surged 33% to $31.07 ** McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice will acquire OPCH for about $5.8 billions (including debt) (link) ** Option Care shareholders will receive $32.05 per share, representing a 37.1% premium over the company's most recent closing price ** McKesson will invest approximately $1.4 billions for a 49% stake and retains the right to acquire the remaining 51% from CD&R at a future date ** Leerink Partners analysts said the deal is "a logical adjacencies investment, helping McKesson further expand its presence across vertically integrated areas" ** The transaction is expected to complete in the first half of 2027, after which Option Care Health will become a private company ** McKesson shares edged up to $922.41 ** As of the previous trading day's close, OPCH had declined by 26.7% year-to-date

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Lower Oil Prices

09:12 AM EDT, 10/06/2026 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.5% and the actively traded Invesco QQQ Trust (QQQ) was 0.6% higher in Tuesday's premarket activity amid lower oil prices and optimism around tech stocks. US stock futures were also higher, with S&P 500 Index futures up 0.5%, Dow Jones Industrial Average futures advancing 0.7%, and Nasdaq futures gaining 0.7% before the start of regular trading. The US international trade deficit widened to $105.57 billion in August from a $92.83 billion gap in July, compared with a $102.1 billion gap expected in a survey compiled by Bloomberg as of 7:35 am ET. In premarket activity, bitcoin was up by 0.7%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 1% higher, Ether ETF (EETH) advanced 1.6%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat. Power Play: Health Care The State Street Health Care Select Sector SPDR ETF (XLV) advanced 0.3%, while the Vanguard Health Care Index Fund (VHT) and the iShares US Healthcare ETF (IYH) were inactive. The iShares Biotechnology ETF (IBB) was 0.7% higher. Option Care Health (OPCH) shares were up 21% pre-bell Tuesday after McKesson (MCK) and CD&R agreed to buy the company for roughly $5.80 billion. Winners and Losers: Technology The State Street Technology Select Sector SPDR ETF (XLK) gained 0.7%, the iShares US Technology ETF (IYW) was 0.5% higher, and the iShares Expanded Tech Sector ETF (IGM) was inactive. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was inactive, while the iShares Semiconductor ETF (SOXX) rose by 0.5%. Xanadu Quantum Technologies (XNDU) shares were up 7% in premarket activity after the company entered a multiyear deal with GlobalFoundries (GFS). GlobalFoundries was 1.4% higher. Financial The State Street Financial Select Sector SPDR ETF (XLF) advanced 0.3%. Direxion Daily Financial Bull 3X Shares (FAS) was up 0.9%, while its bearish counterpart, Direxion Daily Financial Be

Sector Update: Healthcare

09:05 AM EDT, 10/06/2026 (MT Newswires) -- Healthcare stocks were steady to higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) unchanged. McKesson (MCK) and CD&R have entered into a definitive agreement to acquire Option Care Health (OPCH) for $32.05 per share, reflecting a total enterprise value of about $5.8 billion, the companies said. Shares of Option Care Health were nearly 33% higher pre-bell.

Updated version 3 - McKesson and CD&R will privatize infusion therapy provider Option Care in a $5.8 billion deal

Sneha S K, Reuters, October 6 - Pharmaceutical distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice (CD&R) reached an agreement on Tuesday to take infusion therapy provider Option Care Health (OPCH.O) private in a deal valued at approximately $5.8 billion, including debt. The acquisition price of $32.05 per share represents a 37.1% premium over Option Care's most recent closing price. The stock rose 33% in pre-market trading to $31.11. This deal, part of McKesson’s latest efforts to expand in healthcare services, marks another acquisition of a home healthcare provider by a private equity fund following the Enhabit deal. Option Care Health is the largest independent provider of infusion therapy in the US, serving over 308,000 patients annually through more than 197 service locations, offering home and outpatient infusions, specialty pharmacy services, and care for complex conditions. Demand for home healthcare in the US has been growing amid an aging population and as more patients opt for care outside of high-cost settings such as hospitals. After the deal closes, CD&R will hold the majority stake, while McKesson will own a minority stake. Option Care Health will continue to operate as an independent company, led by its own management team. Under the transaction terms, McKesson will invest about $1.4 billion for a 49% stake and retain the right to purchase the remaining 51% from CD&R at a later date. Leerink Partners analyst Michael Cherny noted in a report Monday evening that the deal aligns McKesson with the trend of shifting healthcare services away from hospitals and institutions. In addition, given McKesson’s operation of Canada’s leading infusion and injection network Inviva, the transaction expands its footprint in US home infusion services. McKesson’s oncology and multi-specialty business unit, which includes infusion services, generated revenue of $14.2 billion in the latest quarter, up 33% year-over-year, driven by specialty drug distribution and contributions from acquisitions. The deal is expected to close in the first half of 2027, after which Option Care Health will become a private company.

Updated version 2 - McKesson and CD&R will privatize infusion therapy service provider Option Care in a $5.8 billion deal.

Reuters, October 6 – Pharmaceutical distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice (CD&R) reached an agreement on Tuesday to take infusion therapy provider Option Care Health (OPCH.O) private, in a deal valued at approximately $5.8 billions, including debt. The acquisition offer of $32.05 per share represents a 37.1% premium over Option Care's most recent closing price. As a US pharmaceutical distributor, McKesson is seeking to expand its healthcare services portfolio, and this transaction marks its latest move. It also follows the private equity fund’s previous acquisition of another home health service provider, Enhabit. Option Care Health is the largest independent provider of infusion therapy services in the US, serving over 308,000 patients annually through more than 197 service centers, offering home and outpatient infusions, specialty pharmacy, and care for complex conditions. With an aging population and a growing number of patients choosing care outside costly hospital settings, demand for home healthcare in the US continues to increase. Upon closing, CD&R will hold the majority stake, while McKesson will retain a minority interest. Option Care Health will continue to operate as an independent company led by its existing management team. As per transaction terms, McKesson will invest about $1.4 billions to acquire a 49% stake, with the right to acquire CD&R's remaining 51% interest at a later date. According to Michael Cherny, an analyst at Leerink Partners, this deal positions McKesson in line with the trend of healthcare services shifting away from hospitals and medical institutions to alternative sites of care. Additionally, given McKesson’s current operation of Canada’s leading infusion and injection network, Inviva, the transaction extends its reach in the US home infusion market. McKesson’s oncology and multi-specialty business segments, including infusion services, posted revenues of $14.2 billions in the most recent quarter, up 33% year-over-year, benefiting from specialty drug distribution and contributions from acquisitions. The deal is expected to close in the first half of 2027, after which Option Care Health will become a private company.

McKesson, CD&R to Acquire Option Care Health for $5.8 Billion

08:23 AM EDT, 10/06/2026 (MT Newswires) -- McKesson (MCK) and CD&R have entered into a definitive agreement to acquire Option Care Health (OPCH) for $32.05 per share, reflecting a total enterprise value of about $5.8 billion, the companies said Tuesday. After the transaction closes, which is expected to occur in H1 2027, CD&R will hold a majority interest of 51% in Option Care Health, while McKesson will invest $1.4 billion to hold the remaining 49%. Option Care Health will remain a separate company led by its own management team.

BRIEF-Cd&R And Mckesson Corporation Sign Agreement To Acquire Option Care Health

Mckesson Corp MCK.N: CD&R AND MCKESSON CORPORATION SIGN AGREEMENT TO ACQUIRE OPTION CARE HEALTH CD&R AND MCKESSON CORPORATION SIGN AGREEMENT TO ACQUIRE OPTION CARE HEALTH MCKESSON CORP - CD&R AND MCKESSON TO BUY OPTION CARE HEALTH FOR $32.05 PER SHARE, $5.80 BILLION ENTERPRISE VALUE MCKESSON CORP - OPTION CARE HEALTH TO REMAIN SEPARATE COMPANY LED BY OWN MANAGEMENT TEAM MCKESSON CORP - CD&R TO HOLD MAJORITY, MCKESSON MINORITY OWNERSHIP IN OPTION CARE HEALTH MCKESSON CORP - DEAL VALUE REPRESENTS 37% PREMIUM TO OCT 5, 2026 OPTION CARE HEALTH SHARE PRICE MCKESSON CORP - CD&R TO HOLD 51% INTEREST, MCKESSON TO INVEST $1.40 BILLION FOR 49% INTEREST MCKESSON CORP - DEAL EXPECTED TO CLOSE IN FIRST HALF OF 2027, SUBJECT TO APPROVALS MCKESSON CORP - OPTION CARE HEALTH TO WITHDRAW FINANCIAL GUIDANCE AND CANCEL Q3 2026 EARNINGS CALL Source text: ID:nBw8y2jrpa Further company coverage: MCK.N

--McKesson, CD&R to Buy Option Care Health for Roughly $5.80 Billion

08:15 AM EDT, 10/06/2026 (MT Newswires) -- McKesson, CD&R to Buy Option Care Health for Roughly $5.80 Billion

CD&R, McKesson agree to buy Option Care Health for $32.05 a share

CD&R and McKesson agreed to acquire Option Care Health for USD 32.05 per share, valuing the business at about USD 5.8 billion. CD&R will own about 51% at closing; McKesson will invest about USD 1.4 billion for about 49%. The deal implies a roughly 37% premium to Option Care Health’s Oct. 5, 2026 close. Closing is expected in the first half of 2027, subject to shareholder vote and required regulatory clearances. Option Care Health is expected to be delisted from Nasdaq and become privately held once the transaction closes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clayton, Dubilier & Rice LLC published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.

Option Care Health Is Withdrawing Its Previously Disclosed Fincl Guidance

Option Care Health Is Withdrawing Its Previously Disclosed Fincl Guidance

CD&R Will Hold a Majority Interest of About 51% in Option Care Health

CD&R Will Hold a Majority Interest of About 51% in Option Care Health

McKesson: Transaction Also Establishes a Framework for McKesson's Future Acquisition of CD&R's Interest in Option Care Health >MCK

McKesson: Transaction Also Establishes a Framework for McKesson's Future Acquisition of CD&R's Interest in Option Care Health >MCK

McKesson Will Invest About $1.4 B for Minority Interest of Approximately 49%

McKesson Will Invest About $1.4 B for Minority Interest of Approximately 49%

McKesson, CD&R agree to buy Option Care Health for $32.05 a share in $5.8 billion deal

CD&R, McKesson, and Option Care Health agreed to acquire Option Care Health for USD 32.05 per share. Deal values Option Care Health at about USD 5.8 billion enterprise value. CD&R to hold about 51% at close; McKesson to invest about USD 1.4 billion for about 49%. Option Care Health expected to remain a separate company under its existing management team. Closing targeted for the first half of calendar 2027; Option Care Health shares to be delisted, making it privately held. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005837505) on October 06, 2026, and is solely responsible for the information contained therein.